Magnetic resonance spectroscopy in Alzheimer’s disease

References

• KantarciK1H magnetic resonance spectroscopy in dementiaBr J Radiol200780Spec No 2:S146S15218445744
   PubMed Web of Science ®Google Scholar
• RossBDBlumlSCowanRDanielsenEFarrowNTanJIn vivo MR spectroscopy of human dementiaNeuroimaging Clin N Am1998848098229769343
   PubMed Web of Science ®Google Scholar
• ValenzuelaMJSachdevPMagnetic resonance spectroscopy in ADNeurology200156559259811261442
   PubMed Web of Science ®Google Scholar
• KlunkWEPanchalingamKMoossyJMcClureRJPettegrewJWN-acetyl-L-aspartate and other amino acid metabolites in Alzheimer’s disease brain: a preliminary proton nuclear magnetic resonance studyNeurology1992428157815851353623
   PubMed Web of Science ®Google Scholar
• BatesTEStrangwardMKeelanJDaveyGPMunroPMClarkJBInhibition of N-acetylaspartate production: implications for 1H MRS studies in vivoNeuroreport199678139714008856684
   PubMed Web of Science ®Google Scholar
• ChengLLNewellKMalloryAEHymanBTGonzalezRGQuantification of neurons in Alzheimer and control brains with ex vivo high resolution magic angle spinning proton magnetic resonance spectroscopy and stereologyMagn Reson Imaging200220752753312413598
   PubMed Web of Science ®Google Scholar
• BrooksWMStidleyCAPetropoulosHMetabolic and cognitive response to human traumatic brain injury: a quantitative proton magnetic resonance studyJ Neurotrauma200017862964010972240
   PubMed Web of Science ®Google Scholar
• BendszusMReentsWFrankeDBrain damage after coronary artery bypass graftingArch Neurol20025971090109512117356
   PubMedGoogle Scholar
• HuggJWKuznieckyRIGilliamFGMorawetzRBFraughtREHetheringtonHPNormalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imagingAnn Neurol19964022362398773605
   PubMed Web of Science ®Google Scholar
• ModregoPJPinaMAFayedNDiazMChanges in metabolite ratios after treatment with rivastigmine in Alzheimer’s disease: a nonrandomised controlled trial with magnetic resonance spectroscopyCNS Drugs2006201086787716999455
   PubMed Web of Science ®Google Scholar
• BraakHBraakENeuropathological stageing of Alzheimer-related changesActa Neuropathologica19918242392591759558
   PubMed Web of Science ®Google Scholar
• KantarciKJackCRJrXuYCRegional metabolic patterns in mild cognitive impairment and Alzheimer’s disease: A 1H MRS studyNeurology200055221021710908893
   PubMed Web of Science ®Google Scholar
• MillerBLMoatsRAShonkTErnstTWoolleySRossBDAlzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopyRadiology199318724334378475286
   PubMed Web of Science ®Google Scholar
• ShonkTKMoatsRAGiffordPProbable Alzheimer disease: diagnosis with proton MR spectroscopyRadiology1995195165727892497
   PubMed Web of Science ®Google Scholar
• FrederickBBSatlinAYurgelun-ToddDARenshawPFIn vivo proton magnetic resonance spectroscopy of Alzheimer’s disease in the parietal and temporal lobesBiol Psychiatry19974221471509209733
   PubMed Web of Science ®Google Scholar
• JessenFBlockWTraberFProton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with ADNeurology200055568468810980734
   PubMed Web of Science ®Google Scholar
• SchuffNAmendDLMeyerhoffDJAlzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brainRadiology19982071911029530304
   PubMed Web of Science ®Google Scholar
• TedeschiGBertolinoALundbomNCortical and subcortical chemical pathology in Alzheimer’s disease as assessed by multislice proton magnetic resonance spectroscopic imagingNeurology19964736967048797467
   PubMed Web of Science ®Google Scholar
• ZhuXSchuffNKornakJEffects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imagingAlzheimer Dis Assoc Disord2006202778516772742
   PubMed Web of Science ®Google Scholar
• ShiinoAMatsudaMMorikawaSInubushiTAkiguchiIHandaJProton magnetic resonance spectroscopy with dementiaSurg Neurol19933921431478394604
   PubMedGoogle Scholar
• BarkerPBLeeRRMcArthurJCAIDS dementia complex: evaluation with proton MR spectroscopic imagingRadiology1995195158647892496
   PubMed Web of Science ®Google Scholar
• BitschABruhnHVougioukasVInfammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopyAJNR Am J Neuroradiol19992091619162710543631
   PubMed Web of Science ®Google Scholar
• GlanvilleNTByersDMCookHWSpenceMWPalmerFBDifferences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial originBiochimica et Biophysica Acta1989100421691792546591
   PubMed Web of Science ®Google Scholar
• HuangWAlexanderGEChangLBrain metabolite concentration and dementia severity in Alzheimer’s disease: a (1)H MRS studyNeurology200157462663211524470
   PubMed Web of Science ®Google Scholar
• KantarciKPetersenRCBoeveBF1H MR spectroscopy in common dementiasNeurology20046381393139815505154
   PubMed Web of Science ®Google Scholar
• MeyerhoffDJMacKaySConstansJMAxonal injury and membrane alterations in Alzheimer’s disease suggested by in vivo proton magnetic resonance spectroscopic imagingAnn Neurol199436140478024260
   PubMed Web of Science ®Google Scholar
• PfefferbaumAAdalsteinssonESpielmanDSullivanE VLimKOIn vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal agingMagn Reson Med199941227628410080274
   PubMed Web of Science ®Google Scholar
• KrishnanKRCharlesHCDoraiswamyPMRandomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer’s diseaseAm J Psychiatry2003160112003201114594748
   PubMed Web of Science ®Google Scholar
• MoatsRAErnstTShonkTKRossBDAbnormal cerebral metabolite concentrations in patients with probable Alzheimer diseaseMagn Reson Med19943211101158084225
   PubMed Web of Science ®Google Scholar
• RoseSEde ZubicarayGIWangDA 1H MRS study of probable Alzheimer’s disease and normal aging: implications for longitudinal monitoring of dementia progressionMagn Reson Imaging199917229129910215485
   PubMed Web of Science ®Google Scholar
• SchuffNAmendDEzekielFChanges of hippocampal N-acetyl aspartate and volume in Alzheimer’s disease. A proton MR spectroscopic imaging and MRI studyNeurology1997496151315219409338
   PubMed Web of Science ®Google Scholar
• ChantalSLabelleMBouchardRWBraunCMBoulangerYCorrelation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer diseaseArch Neurol200259695596212056931
   PubMedGoogle Scholar
• KleinJMembrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipidsJ Neural Transm20001078–91027106311041281
   PubMed Web of Science ®Google Scholar
• WurtmanRJBJMarieJC“Autocannibalism” of choline-containing membrane phospholipids in the pathogenesis of Alzheimer’s diseaseNeurochem Int1985736937220492936
   PubMed Web of Science ®Google Scholar
• SatlinABodickNOffenWWRenshawPFBrain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer’s disease: changes after treatment with xanomeline, an M1 selective cholinergic agonistAm J Psychiatry199715410145914619326834
   PubMed Web of Science ®Google Scholar
• KantarciKWeigandSDPetersenRCLongitudinal 1H MRS changes in mild cognitive impairment and Alzheimer’s diseaseNeurobiol Aging20072891330133916860440
   PubMed Web of Science ®Google Scholar
• AntuonoPGJonesJLWangYLiSJDecreased glutamate + glutamine in Alzheimer’s disease detected in vivo with (1)H-MRS at 0.5 TNeurology200156673774211274307
   PubMed Web of Science ®Google Scholar
• HattoriNAbeKSakodaSSawadaTProton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer’s diseaseNeuroreport200213118318611924885
   PubMed Web of Science ®Google Scholar
• BarthaRSmithMRupsinghRRylettJWellsJLBorrieMJHigh field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer diseaseProg Neuropsychopharmacol Biol Psychiatry200832378679318252268
   PubMed Web of Science ®Google Scholar
• RupsinghRBorrieMSmithMWellsJLBarthaRReduced hippocampal glutamate in Alzheimer diseaseNeurobiol Aging201132580281019501936
   PubMed Web of Science ®Google Scholar
• PennerJRupsinghRSmithMWellsJLBorrieMJBarthaRIncreased glutamate in the hippocampus after galantamine treatment for Alzheimer diseaseProg Neuro-Psychopharmacol Biol Psychiatry2010341104110
   Web of Science ®Google Scholar
• ChenSQWangPJTenGJZhanWLiMHZangFCRole of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer’s disease in APP/PS1 transgenic miceDement Geriatr Cogn Disord200928655856620093832
   PubMed Web of Science ®Google Scholar
• von KienlinMKunneckeBMetzgerFAltered metabolic profile in the frontal cortex of PS2 APP transgenic mice, monitored throughout their life spanNeurobiol Dis2005181323915649694
   PubMed Web of Science ®Google Scholar
• ChenSQCaiQShenYYAge-related changes in brain metabolites and cognitive function in APP/PS1 transgenic miceBehav Brain Res201223511622828014
   PubMed Web of Science ®Google Scholar
• KantarciKKnopmanDSDicksonDWAlzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurementsRadiology2008248121022018566174
   PubMed Web of Science ®Google Scholar
• JessenFBlockWTraberFDecrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patientsNeurology200157593093211552037
   PubMed Web of Science ®Google Scholar
• SchottJMFrostCMacManusDGIbrahimFWaldmanADFoxNCShort echo time proton magnetic resonance spectroscopy in Alzheimer’s disease: a longitudinal multiple time point studyBrain2010133113315332220739347
   PubMed Web of Science ®Google Scholar
• AcklNIsingMSchreiberYAAtiyaMSonntagAAuerDPHippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer’s diseaseNeurosci Lett20053841–2232815905028
   PubMed Web of Science ®Google Scholar
• DoraiswamyPMCharlesHCKrishnanKRPrediction of cognitive decline in early Alzheimer’s diseaseLancet1998352914116789853445
   PubMed Web of Science ®Google Scholar
• KantarciKSmithGEIvnikRJ1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer’s diseaseJ Int Neuropsychol Soc20028793494212405545
   PubMed Web of Science ®Google Scholar
• Kwo-On-YuenPFNewmarkRDBudingerTFKayeJABallMJJagustWJBrain N-acetyl-L-aspartic acid in Alzheimer’s disease: a proton magnetic resonance spectroscopy studyBrain Res199466721671747697354
   PubMed Web of Science ®Google Scholar
• FernandezAGarcia-SeguraJMOrtizTProton magnetic resonance spectroscopy and magnetoencephalographic estimation of delta dipole density: a combination of techniques that may contribute to the diagnosis of Alzheimer’s diseaseDement Geriatr Cogn Disord2005202–316917716020946
   PubMed Web of Science ®Google Scholar
• KantarciKXuYShiungMMComparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer’s diseaseDement Geriatr Cogn Disord200214419820712411762
   PubMed Web of Science ®Google Scholar
• Martinez-BisbalMCAranaEMarti-BonmatiLMollaECeldaBCognitive impairment: classification by 1H magnetic resonance spectroscopyEur J Neurol200411318719315009164
   PubMed Web of Science ®Google Scholar
• MacKaySEzekielFDi SclafaniVAlzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imagingRadiology199619825375458596863
   PubMed Web of Science ®Google Scholar
• SchuffNCapizzanoAADuATSelective reduction of N- acetylaspartate in medial temporal and parietal lobes in ADNeurology200258692893511914410
   PubMed Web of Science ®Google Scholar
• SweetRAPanchalingamKPettegrewJWPsychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathologyNeurobiol Aging200223454755312009504
   PubMed Web of Science ®Google Scholar
• ShinnoHInagakiTMiyaokaTA decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer’s diseaseJ Neurol Sci20072601–213213817540407
   PubMed Web of Science ®Google Scholar
• ChaoLLSchuffNKramerJHReduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patientsNeurology200564228228915668426
   PubMed Web of Science ®Google Scholar
• MetastasioARinaldiPTarducciRConversion of MCI to dementia: role of proton magnetic resonance spectroscopyNeurobiol Aging200627792693215936850
   PubMed Web of Science ®Google Scholar
• KantarciKWeigandSDPrzybelskiSARisk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRSNeurology200972171519152519398707
   PubMed Web of Science ®Google Scholar
• SchneiderJAArvanitakisZBangWBennettDAMixed brain pathologies account for most dementia cases in community-dwelling older personsNeurology200769242197220417568013
   PubMed Web of Science ®Google Scholar
• KattapongVJBrooksWMWesleyMHKodituwakkuPWRosenbergGAProton magnetic resonance spectroscopy of vascular-and Alzheimer-type dementiaArch Neurol19965376786808929176
   PubMedGoogle Scholar
• MacKaySMeyerhoffDJConstansJMNormanDFeinGWeinerMWRegional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imagingArch Neurol19965321671748639067
   PubMedGoogle Scholar
• SchuffNCapizzanoAADuATDifferent patterns of N- acetylaspartate loss in subcortical ischemic vascular dementia and ADNeurology200361335836412913198
   PubMed Web of Science ®Google Scholar
• ShiinoAWatanabeTShirakashiYThe profile of hippocampal metabolites differs between Alzheimer’s disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopyJ Cereb Blood Flow Metab201232580581522314267
   PubMed Web of Science ®Google Scholar
• WaldmanADRaiGSMcConnellJRChaudryMGrantDClinical brain proton magnetic resonance spectroscopy for management of Alzheimer’s and sub-cortical ischemic vascular dementia in older peopleArch Gerontol Geriatr200235213714214764351
   PubMed Web of Science ®Google Scholar
• MiharaMHattoriNAbeKSakodaSSawadaTMagnetic resonance spectroscopic study of Alzheimer’s disease and frontotemporal dementia/Pick complexNeuroreport200617441341616514368
   PubMed Web of Science ®Google Scholar
• ShonkTKMoatsRAGiffordPProbable Alzheimer disease: diagnosis with proton MR spectroscopy. [see comment]Radiology1995195165727892497
   PubMed Web of Science ®Google Scholar
• ErnstTChangLMelchorRMehringerCMFrontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopyRadiology199720338298369169712
   PubMed Web of Science ®Google Scholar
• Gomez-IslaTGrowdonWBMcNamaraMClinicopathologic correlates in temporal cortex in dementia with Lewy bodiesNeurology19995392003200910599772
   PubMed Web of Science ®Google Scholar
• XuanXDingMGongXProton magnetic resonance spectroscopy detects a relative decrease of N-acetylaspartate in the hippocampus of patients with dementia with Lewy bodiesJ Neuroimaging200818213714118333837
   PubMed Web of Science ®Google Scholar
• MolinaJAGarcia-SeguraJMBenito-LeonJProton magnetic resonance spectroscopy in dementia with Lewy bodiesEur Neurol200248315816312373033
   PubMed Web of Science ®Google Scholar
• LimSMKatsifsAVillemagneVLThe 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodiesJ Nucl Med200950101638164519759102
   PubMed Web of Science ®Google Scholar
• TiraboschiPHansenLAAlfordMEarly and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer diseaseArch Gen Psychiatry2002591094695112365882
   PubMed Web of Science ®Google Scholar
• KnopmanDSDeKoskySTCummingsJLPractice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. [see comment]Neurology20015691143115311342678
   PubMed Web of Science ®Google Scholar
• AlbertMSDeKoskySTDicksonDThe diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s diseaseAlzheimers Dement20117327027921514249
   PubMed Web of Science ®Google Scholar
• JackCRJrAlbertMSKnopmanDSIntroduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s diseaseAlzheimers Dement20117325726221514247
   PubMed Web of Science ®Google Scholar
• McKhannGMKnopmanDSChertkowHThe diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s diseaseAlzheimers Dement20117326326921514250
   PubMed Web of Science ®Google Scholar
• RossAJSachdevPSWenWValenzuelaMJBrodatyH1H MRS in stroke patients with and without cognitive impairmentNeurobiol Aging200526687388215718046
   PubMed Web of Science ®Google Scholar
• KantarciKLoweVPrzybelskiSAMagnetic resonance spectroscopy, beta-amyloid load, and cognition in a population-based sample of cognitively normal older adultsNeurology2011771095195821865577
   PubMed Web of Science ®Google Scholar
• JackCRJrKnopmanDSJagustWJHypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascadeLancet Neurol20109111912820083042
   PubMed Web of Science ®Google Scholar
• SailasutaNHarrisKTranTRossBMinimally invasive biomarker confirms glial activation present in Alzheimer’s disease: a preliminary studyNeuropsychiatr Dis Treat2011749549921931491
   PubMed Web of Science ®Google Scholar
• JackCRJrDicksonDWParisiJEAntemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementiaNeurology200258575075711889239
   PubMed Web of Science ®Google Scholar
• SperlingRAAisenPSBeckettLAToward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s diseaseAlzheimers Dement20117328029221514248
   PubMed Web of Science ®Google Scholar
• MurrayMEGraff-RadfordNRRossOAPetersenRCDuaraRDicksonDWNeuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective studyLancet Neurol201110978579621802369
   PubMed Web of Science ®Google Scholar
• WhitwellJLDicksonDWMurrayMENeuroimaging correlates of pathologically defined subtypes of Alzheimer’s disease: a case-control studyLancet Neurol2012111086887722951070
   PubMed Web of Science ®Google Scholar
• WhitwellJLJackCRJrKantarciKImaging correlates of posterior cortical atrophyNeurobiol Aging20072871051106116797786
   PubMed Web of Science ®Google Scholar
• CataniMCherubiniAHowardR(1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain agingNeuroreport200112112315231711496102
   PubMed Web of Science ®Google Scholar
• KantarciKBoeveBFWszolekZKMRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathologyNeurology201075977177820805522
   PubMed Web of Science ®Google Scholar
• den HeijerTSijensPEPrinsNDMR spectroscopy of brain white matter in the prediction of dementiaNeurology200666454054416505309
   PubMed Web of Science ®Google Scholar
• GodboltAKWaldmanADMacManusDGMRS shows abnormalities before symptoms in familial Alzheimer diseaseNeurology200666571872216534109
   PubMed Web of Science ®Google Scholar
• AdalsteinssonESullivanEVKleinhansNSpielmanDMPfefferbaumALongitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer’s diseaseLancet200035592161696169710905250
   PubMed Web of Science ®Google Scholar
• KantarciKProton MRS in mild cognitive impairmentJ Magn Reson Imaging201337477077723526756
   PubMed Web of Science ®Google Scholar
• ChantalSBraunCMBouchardRWLabelleMBoulangerYSimilar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer diseaseBrain Res200410031–2263515019560
   PubMed Web of Science ®Google Scholar